Characterization of the cloned human mu opioid receptor

K. Raynor, H. Kong, A. Mestek, L. S. Bye, M. Tian, J. Liu, L. Yu, T. Reisine

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Abstract

Opioid drugs exert a wide spectrum of physiological and behavioral effects, including effects on pain perception, mood, motor control and autonomic functions. The effects of opioids are mediated via a family of membrane-bound receptors, of which the most extensively characterized are the mu, delta and kappa receptors. We have now cloned the human homolog of the mu opioid receptor and, in the present study, we have examined its pharmacological profile. The human mu receptor has high affinities for several alkaloids of high abuse potential as well as a variety of peptide and nonpeptide drugs characterized previously as mu-selective, but not delta- or kappa-selective. Most importantly, the human mu receptor has higher affinity for morphine and methadone than does the rat mu receptor, despite the fact that these receptors are 95% identical at the amino acid level. The labeling of the receptor by agonist was decreased by nonhydrolyzable GTP analogs and by pertussis toxin treatment of cells expressing the human mu receptor, consistent with the coupling of the receptor to guanine nucleotide binding proteins. The human mu receptor functionally couples to the inhibition of adenylyl cyclase in a stereospecific and naloxone-reversible manner. We have also investigated the distribution of mRNAs encoding the mu receptor in human brain by Northern analysis, which demonstrates the existence of multiple transcripts of 13.5, 11, 4.3 and 2.8 kb, which were highly expressed in the hypothalamus, thalamus and subthalamic nucleus, more moderately expressed in the amygdala and caudate nucleus and which demonstrated lowest levels of expression in the hippocampus, substantia nigra and corpus callosum. The availability of the cloned human mu receptor will facilitate the identification of more specific and selective compounds with greater therapeutic potential and fewer undesirable side effects.

Original languageEnglish (US)
Pages (from-to)423-428
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume272
Issue number1
StatePublished - 1995

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Fingerprint Dive into the research topics of 'Characterization of the cloned human mu opioid receptor'. Together they form a unique fingerprint.

Cite this